Faeth Therapeutics, Inc. SEC filings FTH
Faeth Therapeutics, Inc. has 452 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Nov 3, 2026 | — |
| S-3ASR | Automatic shelf registration | Jun 18, 2026 | — |
| S-3/A | Filing | Jun 10, 2026 | — |
| S-3/A | Filing | Jun 2, 2026 | — |
| S-8 | Employee stock plan registration | May 15, 2026 | — |
| S-3 | Shelf registration | Apr 28, 2026 | — |
| S-8 | Employee stock plan registration | Mar 28, 2025 | — |
| S-8 | Employee stock plan registration | Feb 29, 2024 | — |
| 424B5 | Prospectus supplement | Aug 17, 2023 | — |
| S-8 | Employee stock plan registration | Mar 29, 2023 | — |
| S-8 | Employee stock plan registration | May 10, 2022 | — |
| 424B5 | Prospectus supplement | May 9, 2022 | — |
| S-3/A | Filing | May 9, 2022 | — |
| S-3 | Shelf registration | Mar 15, 2022 | — |
| S-8 | Employee stock plan registration | Feb 10, 2021 | — |
| 424B4 | Prospectus | Feb 4, 2021 | — |
| S-1MEF | Filing | Feb 3, 2021 | — |
| S-1/A | Amended registration statement | Feb 1, 2021 | — |
| S-1 | Registration statement | Jan 15, 2021 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FTH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1829802
- Former names
- Sensei Biotherapeutics, Inc. (until Jun 16, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.